uvstocks.io

Today’s CSR movers

ETR 4.0 ▲ 1.5

SO 3.0 ▲ 1.0

NTAP 3.6 ▲ 0.5

PWR 4.6 ▲ 0.5

SNPS 4.6 ▲ 0.5

APA 3.1 ▲ 0.1

ITW 2.7 ▲ 0.1

CF 2.9 ▼ 0.1

VMC 3.7 ▼ 0.1

COO 3.6 ▼ 0.1

Health Care · NYSE NYSE · DGX

Quest Diagnostics

$235.02 +$3.95 +1.68% CLOSE 09.11.26 AFTER HOURS $233.63

Convergence score

3.9 / 5.0 BULLISH

+0.0 vs last report

Overall valuation

Fairly Valued

Aggregated across multiple horizons

Consensus target (12mo)

$243.26 +3.5%

Range $200.00 — $265.00

Sector

Health Care

NYSE · Tracked daily

Today's snapshot

Where the signals stand.

REPORT 09.11.26

UV Convergence Score

REPORT 09.11.26

3.9

/ 5.0

BULLISH

Consensus signal A

4.0

Consensus signal B

4.0

Consensus signal D

4.0

Analyst average

3.9

Multi-signal aggregate How CSR works →

Day Range

$229.33 – $235.12

52W Range

$171.18 – $247.19

Volume

996.8K

Avg Vol

957.2K

Mkt Cap

$25.94B

P/E

24.92

EPS (TTM)

$9.43

Div Yield

1.49%

Beta

0.55

Today's convergence

Convergence score sits at 3.9 with overall valuation reading as fairly valued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation

Fairly Valued

CSR direction

BULLISH

Last close

$235.02

Sector

Health Care

Valuation

Three horizons

UPDATED 09.11.26

Short term

0–3 MO

No target —

Medium term

3–12 MO

$236+0.5% Buy

Long term

12–36 MO

$238.12+1.3% Fairly Valued

Open valuation →

Analysts

Coverage & consensus

3 PANELS

Mean target (12mo)

$243.26 +3.5%

RANGE $200.00 — $265.00

Analyst consensus

Consensus rating Buy

Blended score 4.0 / 5

Analysts tracked 45

Open analysts →

Financials

Key metrics

LATEST

P/E

24.92

EPS (TTM)

$9.43

Mkt Cap

$25.94B

Div Yield

1.49%

Beta

0.55

52W Range

$171.18 – $247.19

Open financials →

Reports

Valuation breakdown

Three horizons, one consensus.

UPDATED 09.11.26

Short term

0–3 MO

—

Consensus target

No target available

Medium term

3–12 MO

Buy

Consensus target

$236 +0.5%

RANGE $200 – $260

$200NOW $235.02$260

12-month analyst consensus target across covering brokerages.

Long term

12–36 MO

Fairly Valued

Consensus target

$238.12 +1.3%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0

Top-level breakdown

Valuation:	PE Ratio: 24.92	PEG Ratio: -	DE Ratio: -
Free Cash Flow: $909.63M	PB Ratio: -	PS Ratio: -	Dividend: $0.86

Analyst coverage

Blended analyst consensus & targets.

3 PANELS · UPDATED 09.11.26

Analyst consensus RATING · SCORE · PANELS · ANALYSTS

Rating Blended score Panels Analysts

Buy 4.0 3 45

Price targets LOW · MEAN · MEDIAN · HIGH · UPSIDE

Coverage Low Mean Median High Upside

All panels $200.00 $243.26 $250.00 $265.00 +3.5%

Rating distribution STRONG BUY · BUY · HOLD · SELL · STRONG SELL

Coverage SB B H S SS

All panels 3 12 14 0 1

Rating trend CURRENT VS 1M / 2M / 3M

Period Rating Avg Analysts

Current — — —

1 Mo Ago — — —

2 Mo Ago — — —

3 Mo Ago — — —

Most recent analyst action LATEST DESK ACTION

Date

9/8/2026

Firm

UBS Group

Action

Boost Target

Rating

Neutral

Target

$245.00

Full financial snapshot.

UPDATED 09.11.26

Quote snapshot 15 FIELDS

Prev Close

$231.14

Open

$233.20

Day Low

$229.33

Day High

$235.12

Bid

$230.00

Ask

$233.84

52W Low

$171.18

52W High

$247.19

50D Avg

$228.89

200D Avg

$201.80

Volume

996.8K

Avg Vol

957.2K

10D Avg Vol

924.8K

52W Change

26.37%

S&P 52W Change

15.30%

Valuation ratios 10 FIELDS

P/E (TTM)

24.92

P/E (Fwd)

19.49

PEG (Fwd)

1.83

P/S

2.24

P/B

3.44

Book Value

$68.33

EV/Revenue

2.74

EV/EBITDA

13.98

Mkt Cap

25.94B

Enterprise Val

31.67B

Profitability & returns 6 FIELDS

Profit Margin

9.19%

Gross Margin

33.19%

Operating Margin

15.25%

EBITDA Margin

19.60%

Return on Assets

6.40%

Return on Equity

14.60%

Growth 3 FIELDS

Revenue Growth (YoY)

10.20%

Earnings Growth (YoY)

15.00%

Earnings Growth (Q)

13.50%

Balance sheet & cash flow 11 FIELDS

Total Revenue

11.56B

EBITDA

2.27B

Total Cash

626M

Total Debt

6.4B

Cash / Share

$5.67

Revenue / Share

$105.09

Free Cash Flow

909.63M

Operating CF

1.9B

Debt / Equity

81.07

Current Ratio

1.59

Quick Ratio

1.28

Dividend 5 FIELDS

Fwd Dividend

3.44 (1.49%)

Dividend Yield

1.49%

Payout Ratio

26.11%

5Y Avg Yield

1.85%

Ex-Div Date

2026-10-06

Share statistics 7 FIELDS

Shares Out

110.37M

Float

109.81M

Shares Short

3.45M

% Short of Float

3.13%

Short Ratio

4.25

% Held Insiders

0.43%

% Held Institutions

99.03%

Calendar & events 5 FIELDS

Next Earnings

2026-10-20

Fiscal Year End

2025-12-31

Most Recent Qtr

2026-06-30

Last Split

2:1

Split Date

2005-06-21

Company 2 FIELDS

Industry

Diagnostics & Research

Employees

46,000